Kilitch Drugs (India) Limited announced unaudited standalone earnings results for the quarter and six months ended September 30, 2017. For the quarter, the company reported total income from operations of INR 165.149 million against INR 61.829 million a year ago. Profit before exceptional items was INR 23.944 million against loss of INR 10.344 million a year ago. Profit from ordinary activities before tax was INR 23.944 million against loss of INR 10.344 million a year ago. Net profit after tax from the period from continuing operations was INR 22.330 million against loss of INR 8.473 million a year ago. Diluted earnings per share were INR 1.68 against loss of INR 0.64 a year ago. For the six months, the company reported total income from operations of INR 234.797 million against INR 133.385 million a year ago. Profit before exceptional items was INR 21.813 million against loss of INR 19.323 million a year ago. Profit from ordinary activities before tax INR 21.813 million against loss of INR 19.323 million a year ago. Net profit after tax from the period from continuing operations was INR 21.174 million against loss of INR 16.483 million a year ago. Diluted earnings per share were INR 1.59 against loss of INR 1.25 a year ago.